• Home
  • >>>>>>>>>>>>> 2026 & BEYOND MASTER PLAN >>>>>>>>>>>>>>>>
  • TRAINABLE DATA ASSETS IN CORPORATE LEGACY & ORGANIZATION’s STRATEGIC MEMORY (2012 – 2025)
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Cell Therapy in Regenerative Medicine, 2026 and Beyond
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

Part 8: IP Asset Class III: Aggregate Calculations of Views for e-Proceedings and Tweet Collections

Part 8: IP Asset Class III: Aggregate Calculations of Views for

100+ e-Proceedings and

50+ Tweet Collections

To See all Conferences covered by Aviva

  • List of Medical, Pharmaceutical and BioTech Conferences Covered by Aviva Lev-Ari, PhD, RN, 2013 to Present: Total # and Total Views

and

To See all Conferences covered by Dr. Williams

  • List of Medical, Pharmaceutical and BioTech Conferences Covered by Stephen J. Williams, PhD, 2015 to Present: Total # and Total Views

To See all e-Proceedings and all Tweet Collections

https://pharmaceuticalintelligence.com/press-coverage/part-three-conference-eproceedings-deliverables-social-media-analytics/

 

8.1 Grand Total Views of e-Proceedings & Tweet Collections,

2013 – 2019 [Update for 2020-2025 – PENDING]

YEAR
  Tweed Collections
# of Views
$
Grand Total  
$
Potential Revenues from DOWNLOADS
e-Proceedings and Tweet Collections at $100 per item
Grand Total Views
2013 – 2019
     Total              
Aviva Lev-Ari & Stephen J Williams
1,090
109,000
1,368,500
13,685
YEAR
# Events Covered generating e-Proceeding (some events covered by iPhone Tweeting Pictures and Comments, only) Event counted as 1 even if it generated multiple article entires
     e-Proceedings       # of Views
$
   Tweets Collections (TC) generated   
# of Items

2016: Twitter used in Conference coverage

     Total
2013 – 2019
Aviva Lev-Ari
&
Stephen J Williams
60
12,595
1,259,500
36

 

8.2 Archive of Real Time PRESS Coverage of Medical, Pharmaceutical and Biotech Conferences, 2013 to Present by (1) Press Reporter Name (2) Event Date(s) (3) Conference Name (4) e-Proceedings URL (5) Tweet Collection URL

SOURCES

https://pharmaceuticalintelligence.com/press-coverage/

https://pharmaceuticalintelligence.com/press-coverage/part-two-list-of-biotech-conferences-2013-to-present/

https://pharmaceuticalintelligence.com/press-coverage/part-three-conference-eproceedings-deliverables-social-media-analytics/

[Data Collection for Aviva’s Press Coverage  – PENDING]

List of BioTech Conferences 2013 to Present

Total Number of Conferences Covered

by Aviva Lev-Ari, PhD, RN, per year,

2013 – Present, N = 77

 

Total Views of Total # Conferences Covered

by Aviva Lev-Ari, PhD, RN, per year,

2013 – Present, N = ??

 

Total Number of Conferences Covered

by Stephen J. Williams, PhD, per year,

2015 – Present, N = 23

 

Total Views of Total # Conferences Covered

by Stephen J. Williams, PhD, per year,

2015 – Present, N = 3,494

 

8.3  Channels for e-Marketing of Biotech Conferences: IP Asset Class III: e-Proceedings & Tweet Collections

 

Our Journal  http://pharmaceuticalintelligence.com

On 3/3/2020

  • 1,723,362 e-Readers
  • 5,742 Articles
  • 694 Research Categories – Journal Ontology
  • 10,154 Tags
  • 7,379  Global scientists comments

On 12/29/2025

  • 2,523,172 e-Readers
  • 1,561,284 Visitors
  • 6,275 Articles
  • 757 Research Categories – Journal Ontology
  • Tags [Update – PENDING]
  • Global scientists comments [Update – PENDING]

On 3/3/2020

  • Aviva’s +7,164 BIOTECH Followers on LinkedIn

On 12/29/2025

  • Aviva’s 8,793 connections on LinkedIn
  • Aviva’s 9,261 followers  on LinkedIn

http://www.linkedin.com/in/avivalevari

  • Aviva is a Member of +80 LinkedIn Groups in Biotech related fields

https://www.linkedin.com/groups/my-groups

  • LPBI Group’s FaceBook Page

http://www.facebook.com/LeadersInPharmaceuticalBusinessIntelligence

  • We Co-Market and Co-Promote Events

Venture Summit | West – “Where Innovation Meets Capital”, March 23rd & 24th  2020, Santa Clara Convention Center, Silicon Valley

Preliminary Agenda Available and Exclusive Discount to attend Understanding CRISPR: Mechanisms to Applications Symposium in Boston (September 19, 2016)

  • LPBI Group’s X.com [ex-Twitter] Account

http://twitter.com/pharma_BI

  • LPBI Group’s Founder’s Account on X.com [ex-Twitter] 

https://x.com/AVIVA1950

  • Aviva is a LinkedIn (LI) Group Launcher and Manager of Three LI Groups

    Cardiovascular Biotech & Pharma UK & US Networking Group

    918 members (1/2019)

          1,291 members (12/2025)

  • Innovation in Israel

    197 members (1/2019)
    388 member (12/29/2025)

    Leaders in Pharmaceutical Business Intelligence

    342 members (1/2019)

367 members (12/2025) – New Members are following the Company’s Page, below

  • LPBI Group’s Company’s Page on LinkedIn –

    LEADERS IN PHARMACEUTICAL BUSINESS INTELLIGENCE GROUP, LLC, DOING BUSINESS AS LPBI GROUP, NEWTON, MA

639 followers

https://www.linkedin.com/company/9325543?trk=tyah&trkInfo=clickedVertical%3Acompany%2CclickedEntityId%3A9325543%2Cidx%3A1-1-1%2CtarId%3A1439226813927%2Ctas%3ALeaders%20in%20Pharmaceutica

Getting from LinkedIn the Identity of the Followers of LPBI Group’s Page requires an upgrade to the current Premium Account in place [Not pursued, yet].
The Global Geographies of LPBI Group’s Company’s Page on LinedIn.com

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email

Like this:

Like Loading...

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,056 other subscribers
  • Recent Posts

    • Grok thinks like PhDs – Hybrid Model for Autonomous Update of Doctoral Dissertations with Original PhD Student Author editing and acceptance of Grok’s updated output. 3rd Joint article, a pilot study for Validation of an Autonomous Journal Articles Updating System (AJAUS) tested on Autonomous Update of Aviva Lev-Ari, PhD, RN Doctoral Thesis, UC, Berkeley, 1983. January 31, 2026
    • 2026 World Economic Forum, 1/19 – 1/23/2026, Davos, Switzerland, LPBI Group’s KOLs interpretation of AI in Health Videos January 24, 2026
    • Evolving LPBI Group’s Portfolio of Intellectual Properties (IP): From 2021 Vision to 2026 Reality January 12, 2026
    • Aviva Lev-Ari, PhD, RN – Biography ->> Grokepedia Entry January 11, 2026
    • List of Articles included in the Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com January 10, 2026
    • The youngest leader in AI in Health: Tanishq Mathew Abraham, Ph.D. (@iScienceLuvr) January 8, 2026
    • 2026 Grok Multimodal Causal Reasoning on Proprietary Cariovascular Corpus: From 2021 Wolfram NLP Baseline to Thousands of Novel Relationships – A Second Head-to-Head Validation of LPBI’s Domain-Aware Training Advantage January 6, 2026
    • Workflow for Dynamic Linkage and Transition between two Authoring Systems: LPBI Group’s WordPress.com Multi-Authors Authoring System and Microsoft PowerPoint product for Slide show presentation – Part 10.1 in Composition of Methods January 6, 2026
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


%d